Aeiro launches adaptive air purification tech that targets specific contaminants

Aeiro on Oct. 20 introduced patent-pending ionization technology that lets users choose from more than 100 airborne contaminants and automatically adjusts how the system treats the air. The company says the approach is being deployed in commercial and residential settings now, with portable consumer products planned for early 2027.

Why it matters: - Indoor air can contain a shifting mix of wildfire smoke, viruses, allergens, mold and ultrafine particles, and those contaminants do not behave the same way. - Aeiro is trying to move air purification from a fixed-output model to a target-specific system that adjusts to the contaminant a user wants to address. - The company says that could matter in homes and buildings where indoor pollutant levels can rise quickly and change by season, weather, occupancy or outdoor conditions.

What happened: - Aeiro introduced its patent-pending Targeted Bipolar Pulsed Ionization, or TBPI®, technology on Oct. 20, 2026. - The South Padre Island, Texas-based indoor air-quality company says the platform lets users select from more than 100 airborne contaminants. - Aeiro says the system then automatically changes how it delivers ions into the air based on the selected target. - Charlie Waddell, co-founder and CEO/CTO, said the product is designed to give users more control over indoor air concerns such as viruses, wildfire smoke, mold, allergens and ultrafine particles.

The details: - Through the Aeiro app, users choose the air-quality concern they want the system to target. - Aeiro says TBPI® adjusts ion timing, polarity balance and output for the selected contaminant. - The company describes TBPI® as an advancement of conventional needlepoint bipolar ionization. - Traditional needlepoint bipolar ionization systems typically generate positive and negative ions at the same time, which can allow some ions to recombine before reaching occupied space. - Aeiro says TBPI® releases positive and negative ions in controlled pulses with a brief delay between polarities. - That design is intended to reduce immediate recombination and give the system more control over ion delivery. - The operating profiles behind the selectable targets are based on laboratory testing, published scientific research, contaminant characteristics, field testing and input from Aeiro’s microbiology team. - The platform currently includes more than 100 selectable contaminant options. - Aeiro’s technology is being developed and deployed in commercial, healthcare, education, agricultural, aviation and residential settings. - The company says systems are already integrated directly into HVAC equipment. - Portable residential air-purification products are planned for early 2027. - Aeiro says the portable products will use TBPI® and will not require HVAC installation. - The company says its technology builds on more than two decades of Waddell’s work in HVAC and indoor air-quality technology. - Waddell previously founded Global Plasma Solutions, now GPS Air, and helped develop and commercialize needlepoint bipolar ionization technology. - Waddell is an engineer and inventor with more than 50 granted patents.

Between the lines: - Aeiro is framing indoor air quality as a dynamic problem, not a single setting that can be solved with a one-speed device. - The company is also leaning on software-driven control and selectable targets to differentiate itself from conventional ionization systems. - The strategy mirrors the way monitored security systems let users identify a specific issue and respond to it directly.

What's next: - Aeiro plans to bring portable consumer products to market in early 2027. - The company is continuing to develop and deploy the technology across commercial and residential channels. - For more information, see the company’s announcement.

The bottom line: - Aeiro is betting that air purification will shift from generic filtration to adaptive treatment tailored to the contaminant in the room.